Division of Pulmonology, University Hospital Zurich, 8091 Zurich, Switzerland.
Faculty of Medicine, University of Zurich, 8032 Zurich, Switzerland.
Medicina (Kaunas). 2023 Mar 20;59(3):617. doi: 10.3390/medicina59030617.
: Remote patient monitoring (RPM) of vital signs and symptoms for lung transplant recipients (LTRs) has become increasingly relevant in many situations. Nevertheless, RPM research integrating multisensory home monitoring in LTRs is scarce. We developed a novel multisensory home monitoring device and tested it in the context of COVID-19 vaccinations. We hypothesize that multisensory RPM and smartphone-based questionnaire feedback on signs and symptoms will be well accepted among LTRs. To assess the usability and acceptability of a remote monitoring system consisting of wearable devices, including home spirometry and a smartphone-based questionnaire application for symptom and vital sign monitoring using wearable devices, during the first and second SARS-CoV-2 vaccination. : Observational usability pilot study for six weeks of home monitoring with the COVIDA Desk for LTRs. During the first week after the vaccination, intensive monitoring was performed by recording data on physical activity, spirometry, temperature, pulse oximetry and self-reported symptoms, signs and additional measurements. During the subsequent days, the number of monitoring assessments was reduced. LTRs reported on their perceptions of the usability of the monitoring device through a purpose-designed questionnaire. : Ten LTRs planning to receive the first COVID-19 vaccinations were recruited. For the intensive monitoring study phase, LTRs recorded symptoms, signs and additional measurements. The most frequent adverse events reported were local pain, fatigue, sleep disturbance and headache. The duration of these symptoms was 5-8 days post-vaccination. Adherence to the main monitoring devices was high. LTRs rated usability as high. The majority were willing to continue monitoring. : The COVIDA Desk showed favorable technical performance and was well accepted by the LTRs during the vaccination phase of the pandemic. The feasibility of the RPM system deployment was proven by the rapid recruitment uptake, technical performance (i.e., low number of errors), favorable user experience questionnaires and detailed individual user feedback.
远程患者监测(RPM)在许多情况下对于肺移植受者(LTR)的生命体征和症状监测变得越来越重要。然而,将多感觉家庭监测整合到 LTR 中的 RPM 研究却很少。我们开发了一种新型的多感觉家庭监测设备,并在 COVID-19 疫苗接种的背景下对其进行了测试。我们假设多感觉 RPM 和基于智能手机的症状和体征问卷反馈将在 LTR 中得到很好的接受。评估一种由可穿戴设备组成的远程监测系统的可用性和可接受性,该系统包括家庭肺量测定法和基于智能手机的问卷应用程序,用于使用可穿戴设备监测症状和生命体征,这是在 SARS-CoV-2 疫苗接种的第一和第二阶段。
COVIDA 桌面为 LTR 进行为期六周的家庭监测的观察性可用性试点研究。在接种疫苗后的第一周,通过记录身体活动、肺量测定法、体温、脉搏血氧饱和度和自我报告的症状、体征和其他测量数据,进行密集监测。在随后的几天里,减少了监测评估的次数。LTR 通过专门设计的问卷报告他们对监测设备的可用性的看法。
招募了 10 名计划接受第一剂 COVID-19 疫苗接种的 LTR。在密集监测研究阶段,LTR 记录了症状、体征和其他测量数据。报告的最常见不良事件是局部疼痛、疲劳、睡眠障碍和头痛。这些症状的持续时间是接种疫苗后 5-8 天。主要监测设备的依从性很高。LTR 对可用性的评价很高。大多数人愿意继续监测。
COVIDA 桌面在大流行期间的疫苗接种阶段表现出良好的技术性能,并且受到 LTR 的欢迎。通过快速招募、技术性能(即错误数量低)、有利的用户体验问卷和详细的个人用户反馈,证明了 RPM 系统部署的可行性。